Assertion: dapsone gel | /r/HasProperty | 7.5%
Facets:
Source sentences:
text: Dapsone Gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
text: Discontinue Dapsone Gel, 7.5%, if signs and symptoms suggestive of hemolytic anemia occur.
text: A total of 2161 subjects were treated with Dapsone Gel, 7.5%, for 12 weeks in 2 controlled clinical trials.
text: No formal drug-drug interaction studies were conducted with Dapsone Gel, 7.5%.
text: Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions
text: There are no available data on Dapsone Gel, 7.5%, use in pregnant women to inform a drug-associated risk for adverse developmental outcomes.
text: Safety and effectiveness of Dapsone Gel, 7.5%, have not been established in pediatric patients below the age of 12 years.
text: Dapsone Gel, 7.5%, contains dapsone, a sulfone, in an aqueous gel base for topical dermatologic use.
text: In a pharmacokinetic study, male and female subjects 16 years of age or older with acne vulgaris (N=19) received 2 grams of Dapsone Gel, 7.5%, topically to the face, upper chest, upper back and shoulders once daily for 28 days.
text: Long-term safety studies were not conducted with Dapsone Gel, 7.5%, however, in a long-term clinical study of Dapsone Gel, 5% treatment (twice daily), periodic blood samples were collected up to 12 months to determine systemic exposure of dapsone and its metabolites in approximately 500 subjects.
text: The safety and efficacy of once daily use of Dapsone Gel, 7.5%, was assessed in two 12-week multicenter, randomized, double-blind, vehicle-controlled trials.
text: Dapsone Gel, 7.5%, is supplied in the following sizes:
text: Advise patients to apply Dapsone Gel, 7.5%, once daily to the entire face [see Dosage and Administration ( 2 )]
text: Do not apply Dapsone Gel, 7.5% to eyes, mouth, or mucous membranes.
text: What is Dapsone Gel, 7.5%?
text: Dapsone Gel, 7.5%, is a prescription medicine used on the skin (topical) to treat acne in people 12 years and older.
text: Dapsone Gel, 7.5%, has not been studied in children under 12 years of age.
text: Before you use Dapsone Gel, 7.5%, tell your doctor about all of your medical conditions, including if you: have a glucose-6-phosphate dehydrogenase deficiency (G6PD)
text: You and your doctor should decide if you will use Dapsone Gel, 7.5%, or breastfeed.
text: How do I use Dapsone Gel, 7.5%?
text: Gently wash and pat dry the areas of your skin where you will apply Dapsone Gel, 7.5%.
text: What are the possible side effects of Dapsone Gel, 7.5%?
text: These are not all of the possible side effects of Dapsone Gel, 7.5%.
text: How should I store Dapsone Gel, 7.5%?
text: Protect Dapsone Gel, 7.5% from freezing.
text: General information about the safe and effective use of Dapsone Gel, 7.5%.
text: What are the ingredients in Dapsone Gel, 7.5%?
text: (dapsone) Gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
text: Aczone (dapsone) Gel, 7.5%, contains dapsone, a sulfone, in an aqueous gel base for topical dermatologic use.
text: Aczone (dapsone) Gel, 7.5%, is supplied in the following sizes: